Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth

被引：0
|
作者：
Naomi A. van Westen-Lagerweij
Eline Meijer
Elisabeth G. Meeuwsen
Niels H. Chavannes
Marc C. Willemsen
Esther A. Croes
机构：
[1] Trimbos Institute,The Netherlands Expertise Centre for Tobacco Control
[2] Maastricht University,Department of Health Promotion
[3] Leiden University Medical Center,Public Health and Primary Care
来源：
npj Primary Care Respiratory Medicine | / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A number of recent studies have found low percentages of smokers among COVID-19 patients, causing scientists to conclude that smokers may be protected against SARS-CoV-2 infection. National and international media were interested in this story and we soon began receiving questions about this topic in general practice. In this article, we shed light on the process that resulted in the misinterpretation of observational research by scientists and the media. We also point out the methodological flaws of various studies on which hasty conclusions were based. Finally, we address the role of primary healthcare providers in mitigating the consequences of erroneous claims about a protective effect of smoking.
引用
收藏
相关论文
共 50 条
  • [31] COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants
    Padasas, Bill Thaddeus
    Espano, Erica
    Kim, Sang-Hyun
    Song, Youngcheon
    Lee, Chong-Kil
    Kim, Jeong-Ki
    IMMUNE NETWORK, 2023, 23 (02)
  • [32] Antiviral effects and tissue exposure of tetrandrine against SARS-CoV-2 infection and COVID-19
    Liu, Jia
    Wang, Furun
    Wang, Xi
    Fan, Shiyong
    Li, Yufeng
    Xu, Mingyue
    Hu, Hengrui
    Liu, Ke
    Zheng, Bohong
    Wang, Lingchao
    Zhang, Huanyu
    Li, Jiang
    Li, Wei
    Zhang, Wenpeng
    Hu, Zhihong
    Cao, Ruiyuan
    Zhuang, Xiaomei
    Wang, Manli
    Zhong, Wu
    MEDCOMM, 2023, 4 (01):
  • [33] Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)
    Carrascosa, J. M.
    Morillas, V
    Bielsa, I
    Munera-Campos, M.
    ACTAS DERMO-SIFILIOGRAFICAS, 2020, 111 (09): : 734 - 742
  • [34] COVID-19 (SARS-CoV-2) Infection in Pregnancy: A Systematic Review
    Akhtar, Hubba
    Patel, Chandni
    Abuelgasim, Eyad
    Harky, Amer
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2020, 85 (04) : 295 - 306
  • [35] The continued global battle against SARS-CoV-2 and COVID-19
    Deng, Chu-Xia
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (06): : 1440 - 1442
  • [36] COVID-19(SARS-CoV-2 infection) in lymphoma patients: A review
    Valentina Bonuomo
    Isacco Ferrarini
    Michele Dell’Eva
    Eugenio Sbisà
    Mauro Krampera
    Carlo Visco
    World Journal of Virology, 2021, (06) : 312 - 325
  • [37] Human genetics of SARS-CoV-2 infection and critical COVID-19
    Mogensen, Trine H.
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (11) : 1417 - 1421
  • [38] Detection of antibodies against SARS-CoV-2 in patients with COVID-19
    Du, Zhe
    Zhu, Fengxue
    Guo, Fuzheng
    Yang, Bo
    Wang, Tianbing
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (10) : 1735 - 1738
  • [39] Animal and translational models of SARS-CoV-2 infection and COVID-19
    Johansen, M. D.
    Irving, A.
    Montagutelli, X.
    Tate, M. D.
    Rudloff, I
    Nold, M. F.
    Hansbro, N. G.
    Kim, R. Y.
    Donovan, C.
    Liu, G.
    Faiz, A.
    Short, K. R.
    Lyons, J. G.
    McCaughan, G. W.
    Gorrell, M. D.
    Cole, A.
    Moreno, C.
    Couteur, D.
    Hesselson, D.
    Triccas, J.
    Neely, G. G.
    Gamble, J. R.
    Simpson, S. J.
    Saunders, B. M.
    Oliver, B. G.
    Britton, W. J.
    Wark, P. A.
    Nold-Petry, C. A.
    Hansbro, P. M.
    MUCOSAL IMMUNOLOGY, 2020, 13 (06) : 877 - 891
  • [40] SARS-CoV-2 infection (COVID-19): What are we facing?
    Kern, Winfried, V
    Biever, Paul M.
    Rieg, Siegbert
    Panning, Marcus
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (11) : 740 - 746
12345